You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • THU0422 SEL-212: enhanced serum uric acid control in hyperuricemic patients through selective mitigation of anti-drug antibodies against pegsiticase

Citation Tools

Article menu

Download PDFPDF

Poster Presentations
Crystal diseases, metabolic bone diseases and bone diseases other than osteoporosis
THU0422 SEL-212: enhanced serum uric acid control in hyperuricemic patients through selective mitigation of anti-drug antibodies against pegsiticase
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Sands E, Kivitz A, Johnston L, et al
THU0422 SEL-212: enhanced serum uric acid control in hyperuricemic patients through selective mitigation of anti-drug antibodies against pegsiticase
Annals of the Rheumatic Diseases 2017;76:367.